Return to homepagePandemic Pact

Elucidating the mutational trajectories of mature anti-HIV1 and anti-SARS-CoV-2 antibodies through in vitro longitudinal screening

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: UKRI1406

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2026
    2029

  • Known Financial Commitments (USD)

    $854,447.07

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Rushad; Katie PAVRI; Doores

  • Research Location

    United Kingdom

  • Lead Research Institution

    KING'S COLLEGE LONDON

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    1d 1c

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.